Original Article
Journal of Human Hypertension (2005) 19, 103–109. doi:10.1038/sj.jhh.1001786 Published online 9 September 2004
Long-term effects of statins on arterial pressure and stiffness of hypertensives
A Ichihara1, M Hayashi1, Y Koura1, Y Tada1, Y Kaneshiro1 and T Saruta1
1Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
Correspondence: Dr A Ichihara, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. E-mail: atzichi@sc.itc.keio.ac.jp
Received 30 January 2004; Revised 30 July 2004; Accepted 2 August 2004; Published online 9 September 2004.
Abstract
Although lowering blood pressure (BP) reduces aortic stiffness, achieving the recommended BP goal can be difficult. Recent studies have shown that short-term use of statins can reduce BP significantly. To determine the long-term effects of statins on BP and aortic stiffness, a single-blind randomized prospective study was performed on 85 hyperlipidaemic hypertensive patients whose BP was insufficiently controlled by antihypertensive therapy. Every 3 months, aortic stiffness was assessed by measuring pulse wave velocity (PWV). Patients were randomly allocated to groups treated with pravastatin, simvastatin, fluvastatin, or a nonstatin antihyperlipidaemic drug. No significant differences in patient characteristics, kinds of antihypertensive drugs, BP, ankle brachial index, PWV, or serum lipid, creatinine, or C-reactive protein levels were found between the four groups at the start of the study. During the 12-month treatment period, PWV did not change in the pravastatin group or nonstatin group, but it was transiently reduced in the simvastatin group and significantly decreased in the fluvastatin group, even though the doses of the statins used in this study were lower than the usually prescribed dose. All four antihyperlipidaemic drugs significantly decreased serum cholesterol levels without affecting BP, ankle brachial index, or serum triglyceride levels. The C-reactive protein serum levels decreased significantly in the three statin groups but not in the nonstatin group. These results suggest that long-term use of fluvastatin by hyperlipidaemic hypertensive patients is associated with a significant reduction in aortic stiffness without any effect on BP.
Keywords:
ankle-brachial index, C-reactive protein, HMG-CoA reductase inhibitor, lipoproteins, pulse wave velocity
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Statins: another class of antihypertensive agents?
Journal of Human Hypertension Review
Journal of Cerebral Blood Flow & Metabolism Review
Statin therapy and autoimmune disease: from protein prenylation to immunomodulation
Nature Reviews Immunology Review (01 May 2006)
RESEARCH
Kidney International Original Article
Anti-inflammatory and immunomodulatory effects of statins
Kidney International Original Article
